DCGO - NASDAQ
DocGo Inc.
$0.57
-4.1%DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.
At a Glance
Live SnapshotDocGo Inc. Profit Bridge
Profitability Analysis
Gross Margin
Moderate margins typical of competitive industries. Monitor for pricing pressure or rising costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
DocGo Inc. Income Statement
DCGO • NASDAQ
| DocGo Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
REVENUE | |||||||
322.2M | 616.6M | 624.3M | 440.5M | 318.7M | 94.1M | 48.3M | |
GROSS PROFIT | |||||||
(223.4M) | (403M) | (428.9M) | (285.8M) | (209M) | (62.7M) | (35.1M) | |
98.8M | 213.6M | 195.4M | 154.7M | 109.7M | 31.3M | 13.2M | |
OPERATING INCOME | |||||||
(187.9M) | (184.9M) | (180.3M) | (132.9M) | (94.4M) | (46.1M) | (34M) | |
(158.7M) | (157.4M) | (153M) | (116.9M) | (83.6M) | (39.4M) | (28.5M) | |
(13.6M) | (11.6M) | (10.9M) | (5.4M) | (3.3M) | (1.2M) | (1.2M) | |
-89.2M | 28.7M | 15.1M | 21.8M | 15.4M | -14.8M | -20.8M | |
PRE-TAX INCOME | |||||||
(1M) | (2.2M) | (0.0) | (0.0) | (763K) | (204.6K) | (0.0) | |
-1M | -1.9M | 1.7M | 762.7K | -763K | -204.6K | -545.9K | |
(15.7M) | (15.9M) | (16.4M) | (10.6M) | (7.5M) | (5.5M) | (4.2M) | |
-98.3M | -939.7K | 1.2M | 950.3K | 4.4M | 125.9K | -428.3K | |
-187.5M | 27.7M | 16.3M | 22.8M | 19.8M | -14.6M | -21.2M | |
NET INCOME | |||||||
(8.9M) | (14.4M) | (6.2M) | -8M | (615.7K) | (167.4K) | (47K) | |
-182.4M | 20M | 6.9M | 34.6M | 23.7M | -14.4M | -21.2M |
SEC Filings
DCGO - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 11, 2026 | May 11, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 11, 2026 | March 31, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | June 16, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 22, 2026 | April 17, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 16, 2026 | March 16, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 16, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | January 30, 2026 | January 26, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 12, 2025 | December 12, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 10, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 10, 2025 | November 10, 2025 | 2025 |
Related Guides
Continue your DCGO research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.